Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTL0018318 and donepezil interaction study in elderly healthy volunteers
NL-OMON28309Active, not recruiting
- Sponsor
- Heptares Therapeutics
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of HTL0018318 and donepezil in Alzheimer's disease (AD) (3 arms), sponsored by Heptares Therapeutics. Primary endpoints: Treatment-emergent adverse events and serious adverse events, Concomitant medication and 5 more. Started Sep 2016; status: active, not recruiting.
02
Drugs
HTL0018318donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON28309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28309.